We have previously shown that protein kinase D1 (PKD1), charter member of PKD protein family, is downregulated in advanced prostate cancer (PC) and influences androgen receptor (AR) function in PC cells. Other independent studies showed that serine 82 residue in heat shock protein 27 (Hsp27) undergoes substrate phosphorylation by PKD1 and is associated with nuclear transport of AR resulting in increased AR transcriptional activity. In this study, we show that PKD1 interacts and phosphorylates Hsp27 at Ser82 in PC cells, which is mediated by p38-dependent mitogen-activated protein kinase pathway and is necessary for PKD1 repression of AR transcriptional activity and androgen-dependent proliferation of PC cells. The study provides first in vivo evidence that Hsp27 is a mediator of repression of AR function by PKD1 in PC cells, thereby linking the data in the published literature.
Introduction
Protein kinase D1 (PKD1) belongs to a family of novel serine/threonine protein kinases classified as a subfamily within Ca-calmodulin kinases superfamily (Valverde et al., 1994; Manning et al., 2002) . Earlier studies show that PKD1 has a role in cell growth, gene expression, survival, motility, protein trafficking and lymphocyte biology (Wang, 2006; Jaggi et al., 2007; Du et al., 2009) . In intact cells, PKD1 is activated by phorbol esters, bryostatin-1 (a marine-derived macrolactone), G-protein-coupled receptor agonists, such as neurotensin (NT) and bombesin (Bom), and other growth factors (Rozengurt et al., 2005; Evans et al., 2008; Jaggi et al., 2008; Yuan and Rozengurt, 2008) . We initially discovered that PKD1 is downregulated in advanced prostate cancer (PC), and later described its interaction with E-cadherin, b-catenin and androgen receptor (AR) (Jaggi et al., 2003 (Jaggi et al., , 2005 Mak et al., 2008; Syed et al., 2008) . Two other independent studies have recently shown that heat shock protein (Hsp27) is a novel substrate of PKD1 (Doppler et al., 2005) and there is ligand-dependent interaction of Hsp27 and AR in PC cells (Zoubeidi et al., 2007) .
Androgen receptor is a ligand-dependent transcription factor and member of nuclear receptor superfamily, which has a key role in prostate development and malignancy (Simental et al., 1991; Edwards and Bartlett, 2005) . In the absence of ligand, AR receptor is predominantly cytoplasmic, maintained in an inactive but highly responsive state by a large dynamic heterocomplex composed of Hsps, including Hsp90. Ligand binding leads to a conformational change in the AR, dissociation from Hsp90 and is translocated to nucleus by chaperone protein, Hsp27 (Edwards and Bartlett, 2005) . In addition to androgens, several other ligands, such as neuropeptides NT and Bom, can activate AR (Lee et al., 2001) and Hsp27 (Yuan and Rozengurt, 2008) , thus circumventing the normal growth inhibition caused by androgen ablation, clinically resulting in castration-resistant PC.
Heat shock protein27 is a ubiquitous and abundantly expressed member of the small Hsp family that has an important role in the regulation of many cellular functions in response to diverse stress stimuli, cytokines, growth factors and G-protein-coupled receptor agonists (Belka et al., 1995; Haslbeck and Buchner, 2002; Parcellier et al., 2003; Evans et al., 2008; Yuan and Rozengurt, 2008) . Hsp27 is a chaperone responsible for refolding of denatured protein (Dudich et al., 1995) and is thought to have major role in the regulation of apoptosis, organization of the actin cytoskeleton and cell migration (Haslbeck and Buchner, 2002; Parcellier et al., 2003 ). Hsp27 appears in many cell types and it is located mainly in cytosol, and also in perinuclear region, endoplasmic reticulum and nucleus (Zoubeidi et al., 2007) . A high expression level of Hsp27 has inverse relationship with cell proliferation; metastasis and altered expression levels of different phosphorylated forms of Hsp27 expression is also observed in various cancers (Cornford et al., 2000; Rocchi et al., 2004 Rocchi et al., , 2005 So et al., 2007) .
The p38 signaling cascade is one major signaling pathway that regulates Hsp27 (Widmann et al., 1999; Zoubeidi et al., 2007; Yuan and Rozengurt, 2008) . Hsp27 is directly phosphorylated at serine 15, 78 and 82 residues by the p38 kinase substrate mitogen-activated protein kinase (MAPK)-activated protein kinase-2, which influences subcellular distribution of Hsp27 (Stokoe et al., 1992; Rouse et al., 1994; Geum et al., 2002) . In addition to well-established p38/MK2/Hsp27 pathway, other studies showed that tumor producing phorbol ester and vascular endothelial growth factor stimulate the phosphorylation of Hsp27 through a pathway independent of p38 MAPK (Maizels et al., 1998; Evans et al., 2008) . Vascular endothelial growth factor has also been shown to activate PKD1, which induces Hsp27 substrate phosphorylation independent of p38 MAPK (Evans et al., 2008) . Data in the literature and our current study show that PKD1 can induce Hsp27 serine 82 residue phosphorylation either directly or through p38-dependent pathway. The dependency on p38 pathway for PKD1 activity seems to be model dependent (Stokoe et al., 1992; Rouse et al., 1994; Evans et al., 2008) .
Although there is data published in the literature linking interactions among PKD1, Hsp27 and AR, it is important to establish the evidence that PKD1-Hsp27-AR signal transduction axis is functional in vivo in PC cells, because all three proteins are dysregulated in PC and have been shown to influence malignant phenotype of cells. In this study, we confirmed PKD1-Hsp27 interaction, Ser82 phosphorylation after PKD1 activation by either pharmacological agent bryostatin-1 or physiopathological stimulants NT and Bom and that Hsp27 is the mediator of repression of AR transcriptional activity and androgen-AR-dependent cell proliferation by PKD1 in PC cells. The establishment of functional PKD1-Hsp27-AR signal transduction axis in PC cells, which is responsive to physiopathological stimulants such as Bom and NT that are thought to contribute castration-resistant PC, has potential implications in areas of biomarker discovery, cancer therapeutics and biology.
Results

PKD1 and Hsp27 are present in the same protein complex in PC cells
We explored the interaction of PKD1 and Hsp27 in PC cells by immunoprecipitation (IP) assays. Figure 1a confirms that PKD1 and Hsp27 are present in the same protein complex. Co-IP assays were performed using whole cell lysate prepared from LNCaP cells, and protein complexes immunoprecipitated with PKD1 antibody indicated the presence of Hsp27, which was also present in whole cell lysate in Figure 1a (top). The specificity of PKD1 and Hsp27 interaction in PC cells was shown by the absence of PKD1 protein when PKD1 antibody was replaced by IgG. When the blot was stripped and reprobed with PKD1 antibody, full-length PKD1 was present only in lysate and the sample immunoprecipitated by PKD1. In reciprocal co-IP experiment, the full-length PKD1 was detected when the lysate was immunoprecipitated by Hsp27 but not by IgG, as shown in Figure 1a (middle). Full-length Hsp27 was also detected in cell lysate and the sample immunoprecipitated by Hsp27 antibody. We also observed that the interaction between PKD1 and phosphorylated Hsp27 was increased after stimulation of LNCaP cells with bryostatin-1. Bryostatin-treated or untreated cell lysates were immunoprecipitated with PKD1 or IgG antibodies. After western blotting the samples with phosphorylated Hsp27 (Ser82), we found that the presence of phosphorylated Hsp27 was increased in bryostatin-treated cells compared with untreated cells that were absent in IgG antibody-added sample (Figure 1a, bottom) . When the blot was stripped and reprobed with PKD1 antibody, full-length PKD1 was present only in the sample immunoprecipitated by PKD1 and absent in the IgG antibody-added sample.
We then examined the subcellular colocalization of PKD1 and Hsp27 in PC cells by immunofluorescence microscopy. Immunofluorescence microscopy experiments show both PKD1 and Hsp27 in cytosol of LNCaP cells, as shown in Figure 1b . Cytoplasmic colocalization of PKD1 (a), Hsp27 (b), DAPI (4 0 ,6-diamidino-2-phenylindole) (c) and merge of these images (d) in LNCaP cells is shown in the same focal plane. These results corroborate the results from IP experiments that PKD1 and Hsp27 are in close physical proximity in PC cells, suggesting a possible direct or indirect interaction.
To find out the role of PKD1 in localization of AR in nucleus, we have taken C4-2 and PKD1 stably transfected C4-2 (C4-2/PKD1) cells that were treated with dihydrotestosterone (DHT) overnight. The PKD1 expression was confirmed by western blot analysis that was shown in Figure 1c (top). Immunoflurorescence assay of AR with C4-2 and C4-2/PKD1 cells showed the predominant localization of AR in nucleus in C4-2 cells that was suppressed in PKD1-transfected C4-2 cells. In contrast, the cytoplasmic localization of AR is less or little in C4-2 cell, but was increased in C4-2/PKD1 cells compared with parental cells. From the results, we concluded that DHT-induced AR was transported by PKD1 from nucleus to cytoplasm in PC cells.
Physiopathological stimulants NT and Bom and pharmacological PKD1 activator (bryostatin-1) phosphorylates Hsp27 at serine 82 in PC cells Neurotensin and Bom are naturally occurring endogenous peptides distributed across species and several organs in humans, including brain, gut and prostate (Carraway and Leeman, 1976; Martinez and Tache, 2000; Mosca et al., 2005) . Although the exact role of these peptides in normal prostate is unclear, they have been shown to involve in paracrine and autocrine signaling, and may be associated with progression to castration-resistant PC (Moody et al., 2003) . As NT and Bom are known PKD1 activators and PKD1 in turn is involved with secretion of NT in several cell lines, we used the peptides as naturally occurring stimulants to determine whether NT and Bom can induce Hsp27 phosphorylation at Ser82 (known PKD1 substrate). Serum-depleted cultures of LNCaP cells were stimulated LNCaP cells were washed with phosphate-buffered saline, fixed and incubated for 1 h with primary antibodies rabbit polyclonal anti-PKD1 and mouse monoclonal anti-Hsp27. Cells were then probed for 1 h with rhodamine RX and fluorescent isothiocyanateconjugated secondary antibodies. After washing, the cells were mounted on slides with Slow Fade Antifade reagent (with DAPI (4 0 ,6-diamidino-2-phenylindole)). Cytoplasmic localization of PKD1, red (A), Hsp27, green (B), DAPI, blue (C) and merge of these images (D) in LNCaP cells was shown in the same focal plane that demonstrate cytoplasmic colocalization of PKD1 and Hsp27 (yellow). (c) Androgen receptor (AR) localization was modulated by PKD1. The cell lysate of C4-2 and C4-2/PKD1 were subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis separation and western blotted with anti-PKD1 and anti b-actin. Results showed the expression of transfected PKD1 in C4-2/PKD1 cell, which was absent in C4-2 cells. Dihydrotestosterone (DHT) pretreated C4-2 and C4-2/PKD1 cells were washed with phosphate-buffered saline, fixed and incubated with AR antibody for 2 h followed by incubation of isothiocyanate-conjugated secondary antibody. After washing, the cells were mounted with DAPI and analysed for AR localization. Nuclear localization (blue) of AR (red) in C4-2/PKD1 cells was suppressed, but that was increased in cytoplasm compared with C4-2 cells.
Hsp27 mediates repression of AR by PKD1 in PC cells
S Hassan et al with NT and Bom for 15 min, lysed and the extracts were analysed by western blotting using antibodies to detect phosphorylated state of Hsp27 at Ser82. As shown in Figure 2a (top), NT/Bom can induce Hsp27 phosphorylation at Ser82 in LNCaP cells. The lysates were also western blotted to detect phosphorylated PKD1 at Ser916 and shown in Figure 2a (bottom). We observed that NT/Bom could increase phosphorylation of PKD1 at Ser916 in our PC model.
Next, to determine whether PKD1 activator bryostatin-1 induces Hsp27 phosphorylation at Ser82 in PC cells, serum-depleted cultures of LNCaP, C4-2 and C4-2/PKD1 cells were stimulated with bryostatin-1 for 30 min, lysed and the extracts were analysed by western blotting using antibodies to detect phosphorylated state of Hsp27 at Ser82 and PKD1 at Ser916. As shown in Figure 2b , bryostatin-1 can induce Hsp27 phosphorylation at Ser82 or PKD1 phosphorylation at Ser916 in LNCaP or C4-2/PKD1 cells, which have high levels of PKD1 expression, but not in C4-2, which has very low PKD1 expression (Jaggi et al., 2007 Du et al., 2009) . In contrast, PKD1 activator (bryostatin-1) did not phosphorylate Hsp27 at serine 15, which is not a known PKD1 phosphorylation site, indicating the specificity of PKD1-dependent Hsp27 Ser82 phosphorylation in PC cells (data not shown).
PKD1-induced Hsp27 Ser82 phosphorylation is p38 MAPK dependent
The serine 82 of Hsp27 can be phosphorylated by several kinases, including PKD1 (Evans et al., 2008) . Hsp27 has previously been reported to be phosphorylated by MAPK-activated protein kinase-2, and MAPKactivated protein kinase-2 is a known substrate of p38 MAPK (Stokoe et al., 1992; Rouse et al., 1994; Widmann et al., 1999) . To assess whether Hsp27 activation by PKD1 activator (NT, Bom, bryostatin-1) was dependent on p38 MAPK (PKD1-mediated effects can be dependent or independent of p38 MAPK (Stokoe et al., 1992; Rouse et al., 1994; Evans et al., 2008) ), we pretreated the LNCaP cells with p38 MAPK inhibitor, SB203580 (1 mM or 10 mM) or dimethyl sulfoxide control, stimulated with PKD1 activators (NT 20 nM, Bom 10 nM, bryostatin-1 30 nM) and studied phosphorylation of PKD1, p38 MAPK and Hsp27 Ser82. NT and Bom stimulated a rapid activation of PKD1 and p38 MAPK, as shown by western blotting in Figure 3a with antibodies that detected the phosphorylated state of the activation loop series of PKD family members (Ser744 and Ser748 in PKD), and threonine and tyrosine residues of p38 MAPK family members, which correlated with Hsp27 ser82 phosphorylation. Similarly, bryostatin-1 stimulated the activation of PKD1 and p38 MAPK, as shown by western blotting in Figure 3b . Thus PKD1 activators cause striking increase in Hsp27 phosphorylation with concurrent phosphorylation of both PKD1 and p38 MAPK in PC cells, suggesting that these proteins may share an epistatic relationship. Treatment of LNCaP cells with SB203580, at a concentration that did not affect PKD1 phosphorylation, attenuated Hsp27 Ser82 phosphorylation in response to NT and Bom in Figure 3a and bryostatin-1 in Figure 3b . These results suggest that Hsp27 Ser82 phosphorylation induced by NT, Bom and bryostatin-1 is p38 MAP kinase dependent in LNCaP cells, which is possibly downstream of PKD1 and upstream of Hsp27. LNCaP cells were treated with varying concentrations of NT and Bom for 15 min. Cell lysates were subjected to western blotting using antibodies to serine 82 phospho-Hsp27, Hsp27, P-PKD1 at serine 916 and PKD1. (b) LNCaP, C4-2 and C4-2 overexpressing PKD1 (C4-2/PKD1) cells were treated with different concentrations of PKD1 activator, Bryostatin-1, for 30 min. Cell lysates were subjected to western blotting using antibodies to phospho-Hsp27 and Hsp27. Bryostatin-1 induced Hsp27 phosphorylation at Ser82 and PKD1 phosphorylation at Ser916 in LNCaP and C4-2/PKD1 cells but not in C4-2 cells, suggesting that PKD1 phosphorylates serine 82 in PC cells. The densitometry-analysed values were generated for p-Hsp27 in C4-2 and c4-2/PKD1 cells and compared with control values for each.
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Inhibition of PKD1 in PC cells reduces the effect of PKD1 activators on Hsp27 and p38 MAPK phosphorylation To confirm the specificity of PKD1 in mediating NT-, Bom-and bryostatin-1-induced Hsp27 phosphorylation at Ser82 and p38 MAPK in PC, LNCaP cells (known to express high levels of endogenous PKD1 (Jaggi et al., 2003) ) were transfected with either targeted or nontargeted small hairpin RNA (shRNA) PKD1. PKD1 expression was inhibited by more than 70% using PKD1-targeted shRNA in LNCaP cells, and both nontargeted and PKD1-targeted shRNA-transfected LNCaP cells were stimulated with 20 nM NT, 10 nM Bom and with two doses (10 nM or 30 nM) of bryostatin-1. PKD1 knockdown attenuated NT and Bom-induced Hsp27 Ser82 and p38 MAPK phosphorylation, as shown in Figure 4a . Similarly, as shown in Figure 4b , PKD1 knockdown blocked Bryostaion-1-induced Hsp27 Ser82 and p38 MAPK phosphorylation. These results suggest that NT, Bom and bryostatin-1-induced Hsp27 Ser82 and p38 MAPK phosphorylation is mediated through PKD1 in LNCaP cells.
To determine whether pharmacological inhibition of PKD1 activation can also attenuate PKD1 effect on Hsp27 Ser82 and p38 MAPK phosphorylation, we examined the effect of Go6976, most selective commercially available PKD inhibitor on bryostatin-1-induced Hsp27 Ser82 and p38 MAPK phosphorylation in PC cells. LNCaP cells were pretreated with Go6976 (1 mM) for 30 min followed by treatment with bryostatin-1 (30 nM) for another 30 min. As illustrated in Figure 4c , inhibition of PKD1 phosphorylation at serine 916 (phosphorylation at Ser916 correlates with PKD1 catalytic activity) (Rybin et al., 2009) by Go6976 also inhibited the effect of bryostatin-1-induced Hsp27 Ser82 and p38 MAPK phosphorylation. These results suggest that phosphorylation of Hsp27 (Ser82) and p38 MAPK is not only dependent on PKD1 expression but also may depend on PKD1 activation.
Hsp27 interacts with PKD1 to effect AR transcriptional activity in PC cells
We have previously published that PKD1 influences AR-dependent function in PC cells . In this experiment, we explored whether Hsp27 is necessary for PKD1 repression of AR transcriptional activity. When LNCaP cells were transiently transfected with AR, the reporter gene androgen-responsive element luciferase followed by NT 30 nM, Bom 10 nM or DHT 10 nM stimulation, there was significant induction of the reporter gene activity in a ligand-dependent manner (Figures 5a and b) . This result suggests that NT and Bom can substitute for androgen in stimulating the androgen-dependent androgen-responsive element transcription, which was significantly attenuated by transfection with PKD1 or Hsp27 small interfering RNA (siRNA). Co-expression of both PKD1 and Hsp27 siRNA did not have significant additive or synergistic effect on AR transcriptional activity than when they were expressed individually, indicating that PKD1, AR and Hsp27 are in the same pathway. However, downregulation of PKD1 by shRNA could enhance the NT, Bom and DHT-induced AR transcription, which was rescued by co-expression of Hsp27 siRNA, indicating that Hsp27 is necessary for PKD1 repression of AR transcription and that PKD1 is upstream of Hsp27.
Hsp27 interacts with PKD1 to effect AR-mediated cell proliferation Prostate cancer cells respond to androgenic stimulation by proliferation mediated by AR. To investigate the phenotypic effect of PKD1 repression of AR transcriptional activity, we analysed cell proliferation in ARtransfected cells stimulated with androgen, NT or Bom in presence or absence of PKD1, Hsp27 siRNA or both. As shown in Figure 6 , in the presence of DHT (10 nM), there was a significant increase in cell proliferation and this effect was attenuated by PKD1 or Hsp27 siRNA, and co-expression of PKD1 and Hsp27 siRNA did not Figure 3 Effect of p38 mitogen-activated protein kinase (MAPK) inhibitor, SB203580, on protein kinase D1 (PKD1) activatorsinduced heat shock protein 27 (Hsp27) phosphorylation. (a) Effect of p38 MAPK inhibitor, SB203580, on NT/Bom-induced Hsp27 phosphorylation. LNCaP cells were preincubated with 1 & 10 mm of SB203580 for 30 min and then stimulated with neurotensin (NT, 20 nM) and bombesin (Bom, 10 nM) for 15 min. Cell lysates were subjected to western blotting using phospho-specific antibodies to Hsp27, PKD1 and p38 MAPK. The densitometry-analysed values were prepared and compared with control for every panel. (b) LNCaP cells were preincubated with 1 & 10 mm of SB203580 for 30 min and then stimulated with bryostatin-1 for 30 min. Cell lysates were subjected to western blotting using phospho-specific antibodies to Hsp27, PKD1 and p38 MAPK. Results show that serine 82 Hsp27 phosphorylation is decreased by p38 MAPK inhibitor in spite of PKD1 activation, which suggests that PKD1 phosphorylates Hsp27 indirectly through p38 MAPK pathway.
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S Hassan et al show significant additive or synergistic effect on ARdependent cell proliferation. Although we have previously shown that knockdown of PKD1 can enhance cell proliferation in several PC cell lines Syed et al., 2008) , dependency of the effect on Hsp27 is novel. These results confirm that PKD1 repression of AR activity stimulated by androgens or promiscuous physiopathological ligands such as NT or Bom influences cell proliferation and, therefore, may have a role in PC progression.
Discussion
This study provides first in vivo experimental evidence combining the data in the published literature by
showing that PKD1-Hsp27-AR signal transduction pathway is functional and can influence cell proliferation in PC. We have previously shown that PKD1 is present in the same protein complex with AR, and this study provides further evidence that Hsp27 is also present in protein complex with PKD1 and is necessary for PKD1 repression of AR activity in PC cells. Hsp27 has been shown to increase AR transcriptional activity by transporting AR from cytosol to nucleus after binding of the ligand (Zoubeidi et al., 2007) . As Hsp27 is phosphorylated at ser82 after activation of PKD1 in a p38-dependent fashion, it is possible that Hsp27 mediates repression of AR by PKD1 by either preventing nuclear translocation of AR in spite of ligand binding or preventing activity of AR within the nucleus. Our observation showed that PKD1 induced the translocation of AR from nucleus to cytoplasm. Protein kinase D1 is capable of shuttling between different subcellular compartments and is activated in intact cells by physiological stimulus such as NT and Bom or pharmacological activators such as bryostatin-1 (Yuan and Rozengurt, 2008) . NT and Bom have been implicated in PC progression as they can induce LNCaP cell growth in the absence of androgen accompanied by AR activation (Lee et al., 2001) . However, the role of physiological stimuli in PKD1-Hsp27-dependent AR transcription and PC cell proliferation is not known. This study shows that PKD1 can attenuate NT/Bominduced AR transcription and cell proliferation in LNCaP cells, and these effects are dependent on Hsp27. The exact mechanism of PKD1-Hsp27-mediated repression of AR activity remains to be investigated. One potential mechanism is our recent After 48 h, cells were stimulated with neurotensin (NT, 20 nM) and bombesin (Bom, 10 nM) for 15 min. Cell lysates were subjected to western blotting using antibodies to phospho-Hsp27, Hsp27, phospho-p38 MAPK, p38 MAPK, PKD1 and b-actin. Results show that Hsp27 Ser82 and p38 MAPK phosphorylation was consistently reduced with decreased expression of PKD1. (b) Effect of PKD1 knockdown on bryostatin-1-induced Hsp27 Ser 82 and p38 MAPK phosphorylation. LNCaP cells were transfected with control shRNA and PKD1 shRNA. After 48 hours, cells were stimulated with bryostatin-1 (10 or 30 nM) for 30 min. Cell lysates were subjected to western blotting using antibodies to phosphoHsp27, Hsp27, phospho-p38 MAPK, P38 MAPK, PKD1 and b-actin. Results show that Hsp27 Ser82 and p38 MAPK phosphorylation is concomitantly reduced with decreased expression of PKD1. (c) Effect of PKD1 selective inhibitor, Go6976, on bryostatin-1-induced Hsp27 Ser82 and p38 MAPK phosphorylation. LNCaP cells were preincubated with 1 mm of Go6976 for 30 min and then stimulated with bryostatin-1 for 30 min. Cell lysates were subjected to western blotting using antibodies to phospho-Hsp27, Hsp27, phospho-p38 MAPK, P38 MAPK, phospho-PKD1 and PKD1. Results show that phosphorylation of Hsp27 Ser82 is halved but phosphorylation of p38 MAPK is almost completely blocked by PKD1 selective inhibitor.
Hsp27 mediates repression of AR by PKD1 in PC cells S Hassan et al discovery of PKD1-mediated substrate b-catenin, an established co-activator of AR, which may influence AR transcriptional activity after nuclear transport of AR by Hsp27 Du et al., 2009) .
We have previously shown that down-or upregulation of PKD1 expression in several PC cell lines increases or decreases cell proliferation and motility, respectively, which is mediated by b-catenin . b-Catenin is a member of cadherin-catenin complex of proteins that has a role in cell adhesion and proliferation, and is a known co-activator of AR transcriptional activity (Wang et al., 2008) . Interestingly, PKD1 interacts and phosphorylates b-catenin at threonine 112 and 120 residues, and site-directed androgen-dependent androgen-responsive elements (ARE) transcription. LNCaP cells at a density of 0.5 Â 10 4 cells were plated in a 96-well plate. After 24 h, cells were transiently transfected with androgen receptor (AR), ARE-luciferase, pRL-tk luciferase, empty vector, PKD1 in pEGFP.C1 vector, shPKD1 in U6-KS vector, nontargeted small interfering RNA (siRNA) or Hsp27 siRNA at different combinations with Lipofectamine (Invitrogen). After 24 h, cells were incubated with phenol red-free RPMI 1640 in charcoalstripped serum with or without neurotensin (NT, 30 nM), bombesin (Bom, 30 nM) (a) and 5a-dihydrotestosterone (DHT, 10 nM) (b) for another 24 h. The ratio of ARE to pRL-tk luciferase represent relative luciferase units (RLU) with s.e.m. (n ¼ 3). The percentage increase indicates the percentage ratio of normalized luciferase activities between cell cultured without treatment and with NT, Bom or androgen treatments. Asterisk (*) indicates statistical significance (Student's t-test, Po0.05). Although the results show that decreased expression of PKD1 or Hsp27 decreases AR transcriptional activity, there is no cumulative effect after downregulation of PKD1 or Hsp27, suggesting that PKD1-Hsp27 are in the same signaling pathway.
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S Hassan et al mutagenesis of T120 and/or T112 decreases b-catenin transcriptional activity (Du et al., 2009) . Although the effect of T120 or T112 nonphosphorylation mutant on AR activity is not known, PKD1 may influence AR activity through multiple mechanisms, including Hsp27 and b-catenin-mediated pathways. Interestingly, a recent study in breast cancer cells identified that Hsp27, but not Hsps 60, 70 or 90, interacted with b-catenin, suggesting that Hsp 27 phosphorylation by PKD1 may influence transport of b-catenin as well and may mediate PKD1 repression of AR activity (Fanelli et al., 2008) . Although it is widely recognized that Hsp27 is a substrate of p38 MAPK, other studies showed that phorbol esters also stimulate the phosphorylation of Hsp27 in a variety of cell types through a PKCdependent but p38 MAPK-independent pathway (Maizels et al., 1998). We confirm in this paper that a specific p38 MAPK inhibitor, SB203580, inhibited PKD1-induced Hsp27 and p38 MAPK phosphorylation but not PKD1 phosphorylation, indicating that PKD1 is upstream of p38 MAPK and Hsp27. In addition, knockdown of PKD1 by siRNA and chemical inhibition of PKD1 activity by Go6976 attenuates PKD1 activator (NT, Bom and bryostatin-1)-induced p38 MAPK phosphorylation. Thus, in this study, we show that PKD1 phosphorylates Hsp27 at Ser82 in PC cells, which is mediated by p38 MAPK pathway, and clarify this convergent signaling pathway in PC cells. Hsp27 has been shown to undergo direct substrate phosphorylation by PKD1 (Doppler et al., 2005) . In our study, although treatment of p38 MAPK inhibitor attenuates Hsp27 phosphorylation, it did completely abolish Hsp27 phosphorylation (Figure 3b ) in spite of totally blocking p38 MAPK activity, suggesting that PKD1 may directly phosphorylate Hsp27 as well.
Although our study confirms that NT activates PKD1 in PC cells, others have shown that PKD dramatically influences NT secretion in basal and stimulated state in BON human pancreatic carcinoid cell line (Li et al., 2008) . Prostate cells express NT receptors, which on ligand binding promote cell growth and proliferation (Carraway and Hassan, 2007) . Neuroendocrine differentiation is associated with castration resistance in PC, suggesting that NT expression may contribute to autocrine PC growth. The interdependent relationship between NT and PKD1 suggests that NT may be able to influence PC cell function through an autocrine fashion, known to have a role in secretion of NT.
The in vivo evidence provided in this study in cell lines remains to be validated in preclinical models. Nevertheless, the study exposes several potential translational possibilities. Hsp inhibitors, especially Hsp90, are currently in clinical trials and Hsp27 can now be considered a potential therapeutic target (Neckers, 2003) . Progression to castration resistance is the main cause of PC mortality, and novel drugs that work through epistatic mechanism could supplement efficacy of androgen ablative treatment in patients with PC. Moreover, PKD1 belongs to a family of kinases that have proved to be the most successful targets in Effect of protein kinase D1 (PKD1) or/and heat shock protein 27 (Hsp27) on neurotensin (NT), bombesin (Bom) and androgen (DHT, dihydrotestosterone)-induced cell proliferation. LNCaP cells were plated at 4 Â 10 3 per well in 100 ml RPMI 1640 medium in 96-well plate. Cells were transfected with different combinations of empty vector, PKD1, androgen receptor (AR), short hairpin PKD1 (shPKD1) expression plasmids, nontargeted small interfering RNA (siRNA) and Hsp27 siRNA. After 24 h, medium was removed and replaced with phenol red-free RPMI 1640 in charcoal-stripped serum containing NT (30 nM), Bom (30 nM) or DHT (10 nM). MTS (3-(4, 5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) assays were performed 72 h after transfection, as described previously . Cell proliferation is depicted as percentage of increase relative to untreated cells, mean with s.e.m. (n ¼ 4) of a single experiment. Asterisk (*) indicates statistical significant (Student's t-test, Po0.05). The results of these proliferation experiments are consistent with AR transcriptional activity assay (Figure 5) , showing that decreased expression of PKD1 or Hsp27 decreases AR-mediated proliferation, there is no cumulative effect after downregulation of PKD1 or Hsp27, suggesting that PKD1-Hsp27 are in the same signaling pathway.
Hsp27 mediates repression of AR by PKD1 in PC cells S Hassan et al rationale-based drug designing (Jaggi et al., 2007; Gomase and Tagore, 2008) . Bryostatin 1, a PKD activator, has been used in several clinical trials for cancers including prostate with limited success (Roberts et al., 2006; Ku et al., 2008) . Further understanding of PKD1 mechanism of PKD1 activity will provide newer approaches to improve efficacy of activators and inhibitors.
In conclusion, the current study provides in vivo evidence that Hsp27 undergoes phosphorylation after activation of PKD1 through p38 MAPK pathway and is necessary for repression of AR activity. AR repression by PKD1 results in decreased liganddependent cell proliferation, both to physiological stimulant androgens and to physiopathological stimulants NT and Bom. As PKD1, Hsp27 and AR are dysregulated in PC, PKD1-Hsp27-AR interaction provides us a novel signaling pathway worth exploring further to understand PC progression and can be an attractive target for biomarkers evaluation or therapeutic intervention.
Materials and methods
Cell culture, reagents and antibodies Human PC cell lines LNCaP (ATCC, Manassas, VA, USA), C4-2-GFP and C4-2-PKD1-GFP (Jaggi et al., 2005) were grown in RPMI 1640 media with 10% fetal bovine serum (GIBCO BRL, Grand Island, NY, USA) at 37 1C and 5% CO 2 . All inhibitors were from Calbiochem (San Diego, CA, USA). NT, Bom and bryostatin-1 were from Sigma (St Louis, MO, USA). Antibodies to total Hsp27, phospho-Hsp27 (serine 82 and 15), phospho-p38 MAPK (threonine 180/tyrosine 182) were from Cell Signaling Technology (Beverly, MA, USA). Antibodies to PKD1, phospho-PKD1 (serine 744/serine 748, serine 916) and b-actin were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Horseradish peroxidase and fluorescence-conjugated IgGs were from Jackson Immunoresearch Laboratories (West Grove, PA, USA).
Plasmids and siRNA transfection
The vector containing PKD1 was kindly provided by Dr FJ Johannes (Fraunhofer Institute for Interfacial Engineering, Stuttgart, Germany). Construction of anti-PKD1 shRNA expression vector was carried out as described previously (Du et al., 2006) . For shRNA targeted to PKD1 oligos, 5 0 -GA TCCGGAAGGAAATATCTCATGATTCAAGAGATCATG AGATATTTCCTTC-CTTTTTA-3 0 and 5 0 -AGCTTAAAAA GGAGGAAGGAAAATATCTCATGATCTCTTGAATCA TGAGATATTTCCTTCCG-3 0 were annealed and ligated to KSU6 vector that had been digested with BamH1 and HindIII (Du et al., 2006) . Double-stranded siRNA molecules with a two-base overhang at the 3 0 -end of the antisense strand corresponding to Hsp27 site (Rocchi et al., 2006) and a nontargeted siRNA with scramble siRNA duplex as control were purchased from Dharmacon (Lafayette, CO, USA). The human Hsp27 mRNA target sequence for siRNA is 5 0 -AGCUGCAAAAUCCGAUGAGA-3 0 (Rocchi et al., 2006) . For transfection, LNCaP cells were plated on 6-well (1 Â 10 5 ) and 96-well (0.5 Â 10 4 ) plates, and transfections were performed using lipofectamine (Invitrogen, Rockville, MD, USA) according to the manufacturer's protocol.
Co-IP and immunoblotting
LNCaP cells were seeded in 10 cm dishes, and after 48 h, total cell lysate was prepared in triton lysis buffer (Sigma). Aliquots (20 ml) of cell lysate were taken as inputs (5%) for PKD1 and Hsp27 in the co-IP experiment. The remaining cell lysate was incubated with 1 mg of rabbit IgG (control), 1 mg of PKD1 or 1 mg of Hsp27 antibodies, and subsequently with 40 ml protein A/G Sepharose beads. After 2 h of incubation at 4 1C, the protein complex bound to the beads was washed thrice with lysate buffer, and the beads were resuspended in 25 ml sample buffer and subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis. Western blot analysis was performed as described previously ) using anti-Hsp27 or anti-PKD1 as primary antibodies.
Immunofluorescence LNCaP cells were cultured on glass coverslips (40 000 cells per well) until subconfluence and processed for immunofluorescence study. The coverslips were incubated with primary antibodies in 10% goat serum in phosphate-buffered saline. After washing with phosphate-buffered saline, coverslips were incubated with fluorescein isothiocynate, or rhodamine RXconjugated secondary antibodies (Jackson Immunoresearch) for 1 h. The cells were washed in phosphate-buffered saline and mounted on slides with Slow Fade Antifade reagent (with DAPI) (Vector Labs, Burlingame, CA, USA). Photographs were taken at Â 20 magnification using Olympus 1X51 fluorescent microscope (Olympus, Melville, NY, USA) followed by analysis with imaging software.
Transfection and luciferase assay LNCaP cells (0.5 Â 10 5 ) were plated on 96-well plates and transfected using lipofectin (0.5 ml per well; Invitrogen Life Technologies). The total amount of plasmid DNA and siRNA used were normalized by the addition of a control plasmid and siRNA. After 24 h, the transfection media were replaced by charcoal-stripped serum containing phenol red-free RPMI 1640 with or without 30 nM NT, 30 nM Bom or 10 nM DHT for another 24 h. Luciferase or Renilla activities were determined using the Dual-Glo Luciferase Assay System (Promega, Madison, WI, USA) with the aid of a microplate luminometer Luminoskan Ascent (Thermo Electric Corporation, Waltham, MA, USA).
Cell proliferation assays
To determine the effects of PKD1 and/or Hsp27 expression on AR-dependent PC cell growth, MTS (3-(4, 5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) growth and viability assays were used, as described previously . LNCaP cells (4 Â 10 3 per well) were plated in 100 ml RPMI 1640 medium containing 10% serum in 96-well plates and transfected with different combinations of PKD1, PKD1 shRNA expression plasmids or Hsp27 siRNA. The total amount of plasmid DNA and siRNA used were normalized by the addition of a control plasmid and siRNA. After 24 h, the medium was removed and replaced with fresh medium containing phenol red-free RPMI 1640 and charcoal-stripped serum with or without 30 nM NT, 30 nM Bom or 10 nM DHT. Following 72-h incubation after transfection, MTS solution (Promega) was added to each well, and plates were incubated in a humidified atmosphere. The absorbance of the product formazan, which is considered to be directly proportional to the number of living cells, was measured at 490 nm in a spectrophotometer. Relative cell growth of transfected cells with target gene expression was
